Skip to main content
[Preprint]. 2023 Oct 16:rs.3.rs-3406046. [Version 1] doi: 10.21203/rs.3.rs-3406046/v1

Table 1:

Baseline characteristics of the patients included in the study at the time of ERC.

Patient Diagnosis Gender Age IBD IBD Type Cirrhosis Indication for ERC Anatomical location of sample T Bili (mg/dL) Alk Phos (92-279 IU/L)
1 PSC, AIH F 68 No - Yes Stent removal Common hepatic duct, right main duct 3.7 583
2 PSC F 48 Yes UC Yes Elevated bilurribine Distal Common Bile Duct 2.6 37
3 PSC M 77 No - No Stent removal left hepatic duct Left main duct 10.1 394
4 PSC F 70 Yes UC No Right hepatic duct stricture Common Bile Duct, Common hepatic duct 0.3 159
5 PSC F 34 Yes UC No Follow up (? cystic duct malignancy) Bile - 207
6 PSC M 56 Yes UC Yes Elevated bilirubin Common Bile Duct 6.6 552
7 PSC F 60 Yes CD No Follow up (Mass on MRI segment 4) Bile 0.6 58
8 PSC M 30 Yes UC No Surveillance Bile 1.7 210
9 PSC M 63 Yes UC Yes Biliary stent removal Left main duct 2.8 408
10 PSC M 60 No - Yes Surveillance Common hepatic duct 1.7 967
1 non-PSC M 65 No - No Bile leak, benign biliary stricture (Stent removal or exchange) Common Bile Duct bifurcation 0.6 158
2 non-PSC M 72 No - No Benign biliary stricture with lab abnormalities Distal common Bile Duct - 279
3 non-PSC M 80 No - No Pancreatic and biliary stricture Common Bile Duct 1.1 76
4 non-PSC M 69 No - No Chronic pancreatitis, stent change Common Bile Duct 0.3 103
5 non-PSC F 54 No - No Abdominal pain with persistent elevation of liver enzymes. Distal common Bile Duct 0.2 145
6 non-PSC F 62 No - No Follow-up of bile leak Common bile duct, Bile: Cystic duct 0.7 126
7 non-PSC M 66 No - No Biliary stent removal Distal common bile duct 1.1 137

Presence of cirrhosis was determined by one or more of the following diagnostic techniques: elastography, cross-sectional imaging with cirrhotic liver morphology, evidence of portal hypertension and/or liver biopsy.